Bristol Myers Squibb pauses autoimmune trials after life-threatening side effects
Bristol Myers Squibb told regulators, researchers and patient groups in early June it paused closely watched drug research due to life-threatening side effects. The update reached the broader public three months later.
By Xavier Martinez and Lizzy LawrenceBristol Myers Squibb told regulators, researchers and patient advocacy groups in early June that it had paused closely watched drug research because of life-threatening side effects.
It took three months for the company to share that with the broader public.Nova…